Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Maton

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Gastroenterology Clinics of North America|March 1, 1990
Zollinger-Ellison syndrome. Recent advances in the management of the gastrinomaR Vinayek, H Frucht, H C Chiang, et al.
Gastroenterology|February 1, 1990
Reflux esophagitis in patients with Zollinger-Ellison syndromeL S Miller, R Vinayek, H Frucht, et al.
Gastroenterology|February 1, 1988
Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective studyP N Maton, H Frucht, R Vinayek, et al.
British Medical Journal (Clinical Research Ed.)|October 1, 1983
Role of hepatic arterial embolisation in the carcinoid syndromeP N Maton, M Camilleri, G Griffin, et al.
Annals of the New York Academy of Sciences|June 30, 1992
Interaction of calcitonin gene-related peptides with pancreatic acinar cells and dispersed gastric smooth muscle cellsR T Jensen, Z C Zhou, Z F Gu, et al.
Gastroenterology|July 1, 1991
Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndromeR Vinayek, M A Amantea, P N Maton, et al.
The American Journal of Gastroenterology|March 10, 2000
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux diseaseD C Metz, V Pratha, P Martin, et al.
Journal of Clinical Gastroenterology|January 1, 1987
Famotidine: effective treatment of Zollinger-Ellison syndromeJ M Howard, R Vinayek, P N Maton, et al.
Medicine|March 1, 1982
Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrenceP N Maton, J H Iser, A Reuben, et al.
Gastroenterology|December 1, 1990
Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndromeH C Chiang, T M O'Dorisio, S C Huang, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Gastroenterology Clinics of North America|March 1, 1990
Zollinger-Ellison syndrome. Recent advances in the management of the gastrinomaR Vinayek, H Frucht, H C Chiang, et al.
Gastroenterology|February 1, 1990
Reflux esophagitis in patients with Zollinger-Ellison syndromeL S Miller, R Vinayek, H Frucht, et al.
Gastroenterology|February 1, 1988
Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective studyP N Maton, H Frucht, R Vinayek, et al.
British Medical Journal (Clinical Research Ed.)|October 1, 1983
Role of hepatic arterial embolisation in the carcinoid syndromeP N Maton, M Camilleri, G Griffin, et al.
Annals of the New York Academy of Sciences|June 30, 1992
Interaction of calcitonin gene-related peptides with pancreatic acinar cells and dispersed gastric smooth muscle cellsR T Jensen, Z C Zhou, Z F Gu, et al.
Gastroenterology|July 1, 1991
Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndromeR Vinayek, M A Amantea, P N Maton, et al.
The American Journal of Gastroenterology|March 10, 2000
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux diseaseD C Metz, V Pratha, P Martin, et al.
Journal of Clinical Gastroenterology|January 1, 1987
Famotidine: effective treatment of Zollinger-Ellison syndromeJ M Howard, R Vinayek, P N Maton, et al.
Medicine|March 1, 1982
Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrenceP N Maton, J H Iser, A Reuben, et al.
Gastroenterology|December 1, 1990
Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndromeH C Chiang, T M O'Dorisio, S C Huang, et al.
Pageof 12